Full test Russian Vektor COVID-19 vaccine in September: RIA

“o. itemList. length” “this. config. text. ariaShown”

“This. config. text. ariaFermé”

MOSCOW (Reuters) – Clinical trial of a progression of the Russian COVID-19 vaccine through the Vektor Siberian Study Center is expected to be completed in September, the RIA news firm said Friday, bringing out control of Russian fitness.

(Reporting through Andrey Kuzmin; written through Tom Balmforth; edited through David Goodman)

Leave a Comment

Your email address will not be published. Required fields are marked *